Related Experiment Video
Updated: Sep 20, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
[Type 2 diabetes and dyslipidemia. Side effects of "Atypical" neuroleptics?]
1Klinik für Psychiatrie und Psychotherapie-Gerontopsychiatrie, Vivantes Klinikum Hellersdorf, Berlin. t.wetterling@kh-hellersdorf.de
Background And Purpose:
After the introduction of the so-called "atypical antipsychotics" in the clinical experience hyperglycemia as well as increased triglyceride and cholesterol serum levels were reported in patients treated with some of these agents. In this article, the recently published population-based studies are reviewed.
Results:
According to the available data, the risk to develop type 2 diabetes mellitus or hyperlipidemia in patients treated with clozapine and olanzapine is increased. The underlying pathomechanism still remains widely unclear. Since overweight is a known risk factor for type 2 diabetes mellitus, the weight-inducing effect of atypical antipsychotics may play an important role.
Conclusion:
Since metabolic disorders often lead to severe diseases, these side effects of antipsychotics should be paid more attention.
Related Concept Videos
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antipsychotic Drugs: Typical and Atypical Agents
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drug Therapy
Antianxiety Medications
Type II Diabetes II: Pathophysiology